In a separate study, Guo et al. showed that GW4064, an agonist of the farnesoid X receptor (FXR), enhances the chemosensitivity of CRC cells to oxaliplatin by inducing pyroptosis and apoptosis in vitro and by reducing tumor cell growth in vivo [62]. Here, NR1H4 is linked to neoplasm.